Infected blood scandal: Compensation payments to start this year, minister says May 21, 2024 Compensation payments to the victims and families of the infected blood scandal will begin before the end of the year, the government has confirmed.
Mike Ashley’s Frasers Group plots stake in two UK shopping centres May 21, 2024 Mike Ashley’s Frasers Group is reportedly closing in on two shopping centre deals, one of which includes a 50 per cent stake in the King’s property company as the retail behemoth looks to grow its physical estate.
HSBC: Yet another investment bank says ‘buy Britain’ May 21, 2024 It could be time to buy UK stocks says HSBC
Singapore Airlines: One dead and many injured after severe turbulence on flight from London Heathrow May 21, 2024 At least one person been killed nd many others hurt after severe turbulence hit a Singapore bound flight from London.
Losses mount for Lebanese restaurant group Comptoir May 21, 2024 The group behind Lebanese restaurants Comptoir Libanais and Yalla Yalla has reported losses of £1.6m, following what bosses describe as a year of “erratic” footfall and soaring costs.
Smiths Group: Engineering and tech giant on track as new chief settles in May 21, 2024 New Smiths Group chief Roland Carter has overseen a solid first quarter in his first few months at the company.
Court of Appeal denies Tom Hayes’ Supreme Court bid, but certified points leaves the door open to apply directly May 21, 2024 Former Libor trader Tom Hayes application to take his case to the highest court in the UK was refused by the Court of Appeal
Vitesse: London insurtech lands £73m funding round led by US private equity giant KKR May 21, 2024 London-based insurtech Vitesse has secured a new $93m (£73.2m) funding round to support its expansion in the US.
XP Power rejects US giant’s £571m takeover bid which ‘fundamentally’ undervalued firm May 21, 2024 Advanced Energy Industries upped the stakes in its bid for the electronic component supplier XP Power, but its latest offer was ultimately rejected.
Based in an old Bermondsey biscuit factory, this London cancer drug firm just raised millions May 21, 2024 Founded in 2012 by a PhD student, Labgenius uses technology to create more effective and safer antibodies for cancer treatment.